Caixin
Aug 06, 2022 04:07 AM
BUSINESS

Sanofi Invests $306 Million in China Partnership for Novel Cancer Drugs

The deal will give Sanofi a 3.87% stake in Innovent’s issued shares.
The deal will give Sanofi a 3.87% stake in Innovent’s issued shares.

French pharmaceutical giant Sanofi SA agreed to invest 300 million euros ($306 million) in Chinese biotech company Innovent Biologics Inc. to foster collaboration in cancer drug development.

Under the agreement, Sanofi will buy Innovent’s Hong Kong-traded shares at HK$42.42 ($5.40) each, a 20% premium over the stock’s average price for the past 30 trading days, Innovent Thursday said in a filing.

You've accessed an article available only to subscribers
VIEW OPTIONS
Share this article
Open WeChat and scan the QR code
NEWSLETTERS
Get our CX Daily, weekly Must-Read and China Green Bulletin newsletters delivered free to your inbox, bringing you China's top headlines.

We ‘ve added you to our subscriber list.

Manage subscription
PODCAST
China Stories: How a Rich Child Rapist Bribed His Way Off Death Row
00:00
00:00/00:00